Reuters logo
BRIEF-Novartis receives three FDA breakthrough therapy designations for Ilaris
2016年4月27日 / 凌晨5点31分 / 2 年前

BRIEF-Novartis receives three FDA breakthrough therapy designations for Ilaris

April 27 (Reuters) - Novartis Ag :

* Novartis receives three FDA breakthrough therapy designations for Ilaris to treat rare types of periodic fever syndromes

* Says breakthrough therapy designations were granted based on pivotal phase iii trial

* Novartis will work closely with FDA to expedite regulatory review of Ilaris for these conditions

Source text for Eikon:

Further company coverage: (Bengaluru Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below